BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37873068)

  • 21. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.
    Wang DY; Kosowan J; Samsom J; Leung L; Zhang KL; Li YX; Xiong Y; Jin J; Petronis A; Oh G; Wong AHC
    Acta Pharmacol Sin; 2018 May; 39(5):866-874. PubMed ID: 29417943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Druggable epigenetic suppression of interferon-induced chemokine expression linked to
    Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
    Nachiyappan A; Gupta N; Taneja R
    FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos.
    Auclair G; Borgel J; Sanz LA; Vallet J; Guibert S; Dumas M; Cavelier P; Girardot M; Forné T; Feil R; Weber M
    Genome Res; 2016 Feb; 26(2):192-202. PubMed ID: 26576615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expanding role of the Ehmt2/G9a complex in neurodevelopment.
    Deimling SJ; Olsen JB; Tropepe V
    Neurogenesis (Austin); 2017; 4(1):e1316888. PubMed ID: 28596979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression.
    Wang J; Xu H; Ge S; Xue C; Li H; Jing X; Liang K; Zhang X; Zhang C
    Cancer Biol Med; 2021 Oct; 19(6):836-49. PubMed ID: 34633777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to Pluripotency.
    Vidal SE; Polyzos A; Chatterjee K; Ee LS; Swanzey E; Morales-Valencia J; Wang H; Parikh CN; Amlani B; Tu S; Gong Y; Snetkova V; Skok JA; Tsirigos A; Kim S; Apostolou E; Stadtfeld M
    Stem Cell Reports; 2020 Dec; 15(6):1233-1245. PubMed ID: 32976761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structure of the cysteine-rich region from human histone-lysine N-methyltransferase EHMT2 (G9a).
    Kerchner KM; Mou TC; Sun Y; Rusnac DV; Sprang SR; Briknarová K
    J Struct Biol X; 2021; 5():100050. PubMed ID: 34278292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel
    Blackburn PR; Williams M; Cousin MA; Boczek NJ; Beek GJ; Lomberk GA; Urrutia RA; Babovic-Vuksanovic D; Klee EW
    Mol Genet Genomic Med; 2017 Mar; 5(2):141-146. PubMed ID: 28361100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of histone methyltransferase EHMT2 in CD4
    Colaço CS; de Matos AR; Estrêla MS; Rocha-Júnior MC; Otaguiri KK; Rodrigues ES; Takayanagui OM; Covas DT; Kashima S; Pittella Silva F; Haddad R
    Arch Virol; 2017 Oct; 162(10):3131-3136. PubMed ID: 28608127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
    Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
    Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2.
    Leenders R; Zijlmans R; van Bree B; van de Sande M; Trivarelli F; Damen E; Wegert A; Müller D; Ehlert JE; Feger D; Heidemann-Dinger C; Kubbutat M; Schächtele C; Lenstra DC; Mecinović J; Müller G
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2516-2524. PubMed ID: 31350126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB.
    Park SE; Yi HJ; Suh N; Park YY; Koh JY; Jeong SY; Cho DH; Kim CS; Hwang JJ
    Oncotarget; 2016 Jun; 7(26):39796-39808. PubMed ID: 27174920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
    Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
    Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
    Nguyen K; Das B; Dobrowolski C; Karn J
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines.
    Katayama K; Ishii K; Tsuda E; Yotsumoto K; Hiramoto K; Suzuki M; Yasumatsu I; Igarashi W; Torihata M; Ishiyama T; Katagiri T
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127475. PubMed ID: 32781218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1/2 in Shank3-deficient mice.
    Wang ZJ; Zhong P; Ma K; Seo JS; Yang F; Hu Z; Zhang F; Lin L; Wang J; Liu T; Matas E; Greengard P; Yan Z
    Mol Psychiatry; 2020 Oct; 25(10):2517-2533. PubMed ID: 30659288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the Euchromatic Histone-Lysine
    Urrutia G; de Assuncao TM; Mathison AJ; Salmonson A; Kerketta R; Zeighami A; Stodola TJ; Adsay V; Pehlivanoglu B; Dwinell MB; Zimmermann MT; Iovanna JL; Urrutia R; Lomberk G
    Front Cell Dev Biol; 2021; 9():681153. PubMed ID: 34249932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome.
    Iacono G; Dubos A; Méziane H; Benevento M; Habibi E; Mandoli A; Riet F; Selloum M; Feil R; Zhou H; Kleefstra T; Kasri NN; van Bokhoven H; Herault Y; Stunnenberg HG
    Nucleic Acids Res; 2018 Jun; 46(10):4950-4965. PubMed ID: 29554304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.